Genmab reported DKK1.17B in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Amarin AMRN:US $ -12.97M 21.83M
Argen X Bv ARGX:BB -230867000 336.12M
AstraZeneca AZN:LN 1954M 415M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Exelixis EXEL:US $ 53.26M 71.63M
Galapagos GLPG:NA € -64.46M 0.5M
Genmab GEN:DC DK 1171M 749M
GN Store Nord GN:DC DK 567M 15M
H. Lundbeck A/S LUN:DC 643M 159M
Immunogen IMGN:US $ -37.34M 6.6M
Insmed INSM:US $ -115292000 1.41M
Lonza Group LONN:SW 496.49M 151.49M
Novartis NOVN:VX SF 4544M 120M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
William Demant Holding WDH:DC 1.54B 226M